JP2015521922A5 - - Google Patents

Info

Publication number

JP2015521922A5

JP2015521922A5 JP2015520702A JP2015520702A JP2015521922A5 JP 2015521922 A5 JP2015521922 A5 JP 2015521922A5 JP 2015520702 A JP2015520702 A JP 2015520702A JP 2015520702 A JP2015520702 A JP 2015520702A JP 2015521922 A5 JP2015521922 A5 JP 2015521922A5

Authority

JP

Japan

Prior art keywords

catheter

flow

lumen

blood

blood vessel

Prior art date

2013-07-05

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 210000004204 blood vessel Anatomy 0.000 claims description 85
• 239000012530 fluid Substances 0.000 claims description 63
• 238000007789 sealing Methods 0.000 claims description 49
• 230000017531 blood circulation Effects 0.000 claims description 37
• 238000011084 recovery Methods 0.000 claims description 28
• 208000028867 ischemia Diseases 0.000 claims description 10
• 239000008280 blood Substances 0.000 claims description 6
• 210000004369 blood Anatomy 0.000 claims description 6
• 230000015271 coagulation Effects 0.000 claims description 2
• 238000005345 coagulation Methods 0.000 claims description 2
• 238000000034 method Methods 0.000 description 57
• 230000010410 reperfusion Effects 0.000 description 47
• 208000007536 Thrombosis Diseases 0.000 description 27
• 230000002490 cerebral effect Effects 0.000 description 13
• 239000003795 chemical substances by application Substances 0.000 description 11
• 230000010411 postconditioning Effects 0.000 description 11
• 150000001875 compounds Chemical class 0.000 description 9
• 239000012528 membrane Substances 0.000 description 8
• 239000000463 material Substances 0.000 description 7
• 230000002265 prevention Effects 0.000 description 7
• 210000005166 vasculature Anatomy 0.000 description 7
• 206010060840 Ischaemic cerebral infarction Diseases 0.000 description 5
• 229940079593 drug Drugs 0.000 description 5
• 239000003814 drug Substances 0.000 description 5
• 230000005611 electricity Effects 0.000 description 5
• 206010053567 Coagulopathies Diseases 0.000 description 4
• 230000000903 blocking effect Effects 0.000 description 4
• 230000035602 clotting Effects 0.000 description 4
• 230000008602 contraction Effects 0.000 description 4
• UIAGMCDKSXEBJQ-IBGZPJMESA-N 3-o-(2-methoxyethyl) 5-o-propan-2-yl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)[C@H]1C1=CC=CC([N+]([O-])=O)=C1 UIAGMCDKSXEBJQ-IBGZPJMESA-N 0.000 description 3
• 229930012538 Paclitaxel Natural products 0.000 description 3
• 206010063837 Reperfusion injury Diseases 0.000 description 3
• 230000000702 anti-platelet effect Effects 0.000 description 3
• 239000003146 anticoagulant agent Substances 0.000 description 3
• 230000009089 cytolysis Effects 0.000 description 3
• 229960000715 nimodipine Drugs 0.000 description 3
• 229960001592 paclitaxel Drugs 0.000 description 3
• 238000003825 pressing Methods 0.000 description 3
• ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 3
• 230000009467 reduction Effects 0.000 description 3
• 208000037803 restenosis Diseases 0.000 description 3
• QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 3
• 229960002930 sirolimus Drugs 0.000 description 3
• RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 3
• 229940124549 vasodilator Drugs 0.000 description 3
• 239000003071 vasodilator agent Substances 0.000 description 3
• PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 2
• 108010036949 Cyclosporine Proteins 0.000 description 2
• 208000005189 Embolism Diseases 0.000 description 2
• 102000016359 Fibronectins Human genes 0.000 description 2
• 108010067306 Fibronectins Proteins 0.000 description 2
• 208000032382 Ischaemic stroke Diseases 0.000 description 2
• 102000001938 Plasminogen Activators Human genes 0.000 description 2
• 108010001014 Plasminogen Activators Proteins 0.000 description 2
• VEUACKUBDLVUAC-UHFFFAOYSA-N [Na].[Ca] Chemical compound [Na].[Ca] VEUACKUBDLVUAC-UHFFFAOYSA-N 0.000 description 2
• 108010079785 calpain inhibitors Proteins 0.000 description 2
• 229960001265 ciclosporin Drugs 0.000 description 2
• 239000000701 coagulant Substances 0.000 description 2
• 239000002872 contrast media Substances 0.000 description 2
• 229930182912 cyclosporin Natural products 0.000 description 2
• 229920001746 electroactive polymer Polymers 0.000 description 2
• 230000008030 elimination Effects 0.000 description 2
• 238000003379 elimination reaction Methods 0.000 description 2
• 238000009472 formulation Methods 0.000 description 2
• 239000003112 inhibitor Substances 0.000 description 2
• 239000000203 mixture Substances 0.000 description 2
• 229940127126 plasminogen activator Drugs 0.000 description 2
• 230000001737 promoting effect Effects 0.000 description 2
• 229940121926 Calpain inhibitor Drugs 0.000 description 1
• 102100035037 Calpastatin Human genes 0.000 description 1
• 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
• 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
• 230000004888 barrier function Effects 0.000 description 1
• 108010044208 calpastatin Proteins 0.000 description 1
• 230000019522 cellular metabolic process Effects 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 239000011263 electroactive material Substances 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 239000011796 hollow space material Substances 0.000 description 1
• 230000006872 improvement Effects 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 238000012805 post-processing Methods 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• 239000012781 shape memory material Substances 0.000 description 1
• 229960000187 tissue plasminogen activator Drugs 0.000 description 1
• 230000002792 vascular Effects 0.000 description 1